Skip to content

Alaris, SmartSite 21028ERecalls & reported problems

BD Switzerland Sàrl · Extension Set 0.2 Micron Low Protein Binding Filter, Needle-Free Valve 46 cm (18 in) · Class 2

All models of Alaris, SmartSite (160)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10885403234965), received between Oct 15, 2021 and Oct 15, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Complete Blockage” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Complete Blockage1
  • Restricted Flow rate1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 15, 2021Complete Blockage; Restricted Flow rate; Complete Blockage; Restricted Flow rate

    IT WAS REPORTED THAT 2 17 INCH EXT W/.2F 1VLV FIXED LL EXPERIENCED FLOW ISSUES AND WERE CLOGGED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED BY THE CUSTOMER THAT THEY ARE EXPERIENCING QUALITY ISSUE. WE ARE HAVING A SERIOUS QUALITY ISSUE IN OUR NICU.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12639594 ↗

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page